Gene · 3977
Papers2,592
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,592
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multifaceted oncostatin M: novel roles and therapeutic potential of the oncostatin M signaling in rheumatoid arthritis. | Front Immunol | 2023 | 38022540 | PubTator, text mining | PubMed |
| Cytohistological and Immunohistochemical Correlation of Cutaneous Mixed Tumors: A Series of Four Cases and Review of Recent Molecular Updates. | Cureus | 2023 | 38021919 | PubTator, text mining | PubMed |
| A genome-wide and candidate gene association study of preterm birth in Korean pregnant women. | PLoS One | 2023 | 38019868 | PubTator, text mining | PubMed |
| Oxidative stress regulation and related metabolic pathways in epithelial-mesenchymal transition of breast cancer stem cells. | Stem Cell Res Ther | 2023 | 38017510 | PubTator, text mining | PubMed |
| Increased spatial coupling of integrin and collagen IV in the immunoresistant clear cell renal cell carcinoma tumor microenvironment. | bioRxiv | 2023 | 38014063 | PubTator, text mining | PubMed |
| Proteome Network Analysis Identifies Potential Biomarkers for Brain Aging. | J Alzheimers Dis | 2023 | 38007645 | PubTator, text mining | PubMed |
| An Integrative Approach to the Current Treatment of HIV-Associated Neurocognitive Disorders and the Implementation of Leukemia Inhibitor Factor as a Mediator of Neurocognitive Preservation. | Life (Basel) | 2023 | 38004334 | PubTator, text mining | PubMed |
| Structures of the interleukin 11 signalling complex reveal gp130 dynamics and the inhibitory mechanism of a cytokine variant. | Nat Commun | 2023 | 37985757 | PubTator, text mining | PubMed |
| Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers. | Biomark Res | 2023 | 37981718 | PubTator, text mining | PubMed |
| Recent advances in lung organoid development and applications in disease modeling. | J Clin Invest | 2023 | 37966116 | PubTator, text mining | PubMed |
| GREB1L overexpression is associated with good clinical outcomes in breast cancer. | Eur J Med Res | 2023 | 37964281 | PubTator, text mining | PubMed |
| Organ-Specificity of Breast Cancer Metastasis. | Int J Mol Sci | 2023 | 37958607 | PubTator, text mining | PubMed |
| Lipocalin-2: A Nurturer of Tumor Progression and a Novel Candidate for Targeted Cancer Therapy. | Cancers (Basel) | 2023 | 37958332 | PubTator, text mining | PubMed |
| Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies. | Front Oncol | 2023 | 37954086 | PubTator, text mining | PubMed |
| New perspectives in cancer immunotherapy: targeting IL-6 cytokine family. | J Immunother Cancer | 2023 | 37945321 | PubTator, text mining | PubMed |
| Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. | Nature | 2023 | 37938773 | PubTator, text mining | PubMed |
| Endometrial Glucose Metabolism During Early Pregnancy. | Reprod Fertil | 2023 | 37934727 | PubTator, text mining | PubMed |
| Cardiotrophin-1 in Asymptomatic Hypertensive Patients With Mild Diastolic Dysfunction: Potential Prognostic Value in Early Stages of Hypertensive Heart Disease. | Cureus | 2023 | 37927758 | PubTator, text mining | PubMed |
| Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients. | Can J Infect Dis Med Microbiol | 2023 | 37927531 | PubTator, text mining | PubMed |
| PCBP1 regulates LIFR through FAM3C to maintain breast cancer stem cell self-renewal and invasiveness. | Cancer Biol Ther | 2023 | 37927213 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3977/papers?page=13